Psychiatry and Neurology, Neurology · Asheville, NC
NPI
1861406134
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
731 Dogwood Road
Asheville, NC, 28806
Phone (828) 210-9310
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
110,279 services
Medicare patients, 2024
460
Average age 72
Drug cost, 2024
$4.0M
4,323 prescriptions
Company payments, 2025
$2,928
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew A Engelbrecht was code J0585 (injection, onabotulinumtoxina, 1 unit), 36,101 times for 60 patients. In total Matthew A Engelbrecht billed 110,279 services in 53 codes, and Medicare paid $1.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-21.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 36,101 | 60 | $4.59 | $166K |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 10,204 | 18 | $13.93 | $142K |
| 64615 Musculoskeletal | Office | 183 | 60 | $95.78 | $18K |
| 99213 Office E&M - Established | Office | 165 | 120 | $58.62 | $9,672 |
| 99214 Office E&M - Established | Office | 149 | 130 | $84.58 | $13K |
| 96413 Chemotherapy Administration | Office | 135 | 34 | $93.85 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 95 | 81 | $11.01 | $1,045 |
| 99215 Office E&M - Established | Office | 80 | 73 | $123.22 | $9,858 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 58 | 21 | $47.37 | $2,747 |
| 99204 Office E&M - New | Office | 46 | 46 | $113.71 | $5,231 |
| 36415 Venipuncture Blood Collection | Office | 43 | 41 | $8.65 | $372 |
| 99205 Office E&M - New | Office | 41 | 41 | $137.62 | $5,643 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 32 | 25 | $23.71 | $759 |
| 99212 Office E&M - Established | Office | 30 | 22 | $27.87 | $836 |
| 96365 Intravenous Infusion, Hydration | Office | 24 | 14 | $39.89 | $957 |
By year: 2022 $620K for 41,891 services; 2023 $1.4M for 92,318 services; 2024 $1.5M for 110,279 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 41 | $8.65 | $372 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew A Engelbrecht prescribed most often to Medicare patients was Memantine Hcl, with 192 prescriptions and refills. In total Matthew A Engelbrecht wrote 4,323 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 192 | 288 | 60 | $5,349 |
| Gabapentin Generic | 179 | 299 | 58 | $3,522 |
| Tizanidine Hcl Generic | 176 | 281 | 43 | $2,441 |
| Rizatriptan Rizatriptan Benzoate | 166 | 189 | 39 | $3,543 |
| Emgality Pen Galcanezumab-Gnlm | 139 | 150 | 26 | $105K |
| Sumatriptan Succinate Generic | 122 | 167 | 29 | $2,489 |
| Botox Onabotulinumtoxina | 119 | 314 | 39 | $162K |
| Topiramate Generic | 118 | 175 | 28 | $852 |
| Donepezil Hcl Generic | 118 | 195 | 40 | $636 |
| Ubrelvy Ubrogepant | 102 | 102 | 25 | $128K |
| Tramadol Hcl Generic | 102 | 104 | 23 | $870 |
| Duloxetine Hcl Generic | 93 | 154 | 19 | $2,039 |
| Lamotrigine Generic | 80 | 124 | 22 | $1,400 |
| Nurtec Odt Rimegepant Sulfate | 75 | 75 | 19 | $104K |
| Baclofen Generic | 72 | 102 | 18 | $1,250 |
Brand drugs: 869 claims; generic drugs: 3,454 claims; opioid claims: 272.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew A Engelbrecht $2,928 ($2,928 in general payments such as food, travel and fees) from 50 companies. The largest payer was Abbvie Inc. with $472.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 66 | $472 |
| UCB, Inc. UCB.BR | 5 | $161 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $136 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $128 |
| TG Therapeutics, Inc. TGTX | 4 | $117 |
| Biogen, Inc. BIIB | 5 | $96.16 |
| Pfizer Inc. PFE | 4 | $91.86 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $86.67 |
| Neurelis, Inc. | 2 | $85.49 |
| MDD US Operations, LLC | 3 | $70.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.